Abstract:Objective: The expression, prognosis, and related mechanisms of ANXA1 are investigated in glioma, with the objective to find potential therapeutic molecular targets for glioma. Methods: We analyzed the gene expression of ANXA1 using glioma-related databases, including the Chinese Glioma Genome Atlas (CGGA) database, The Cancer Genome Atlas (TCGA) database, and the Gene Expression Omnibus (GEO) database. Moreover, we collected the sample tissues and corresponding paracancerous tissues of 23 glioma patients and then conducted a Western blot experiment to verify the expression and correlate survival of ANXA1. Moreover, we generated survival ROC curves, performing univariate and multivariate Cox analyses and the construction of the nomogram. Differential expression analysis was conducted by high and low grouping based on the median of the ANXA1 gene expression values. We conducted Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis and Gene Set Enrichment Analysis (GSEA) to explore possible mechanisms, and gene co-expression analysis was also performed. Results: The results showed that the ANXA1 expression level was higher in gliomas than in normal tissues, and a high expression level of ANXA1 in gliomas was associated with poorer prognosis. The independent prognosis analysis showed that the ANXA1 gene was an independent prognostic factor of glioma. In the analysis of KEGG and Gene Set Enrichment Analysis (GSEA), it is shown that ANXA1 may play an important role in glioma patients by affecting extracellular matrix (ECM)–receptor interaction and the focal adhesion signal pathway. The core genes, including COL1A1, COL1A2, FN1, ITGA1, and ITGB1, were screened for gene correlation and prognosis analysis. The expression level of the five genes was verified by qPCR in glioma. We concluded that these five core genes and ANXA1 could play a synergistic role in gliomas. Conclusion: The results indicated that a high expression level of ANXA1 leads to worse prognosis and ANXA1 is an independent prognostic factor and a potentially important target for the treatment of gliomas.

Expression and significance of ANXA1 mRNA in chronic gastritis and gastric cancer

Differential Expression of ANXA1 in Benign Human Gastrointestinal Tissues and Cancers

Expression of ANXA1 in Metastasis Carcinoma of Lymph Node in Gastric Cancer and Its Relationship with Prognosis

[Expression of annexin A1 (ANXA1) and A2 (ANXA2) and its significance in benign and malignant lesions of gallbladder].

Expression of TNF-α in the Antral Mucosa of Helicobacter Pylori-Associated Chronic Gastritis

Tissue Microarray Analysis Reveals Strong Clinical Evidence for a Close Association Between Loss of Annexin A1 Expression and Nodal Metastasis in Gastric Cancer

Expressions of ANXA4 and ANXA6 in hilarcholangiocarcinoma and their clinical significance

Expression and Significance of Angiopoietin-2 in Gastric Cancer.

Annexin A6 is down-regulated through promoter methylation in gastric cancer.

Nuclear Localization of Annexin A1 Correlates with Advanced Disease and Peritoneal Dissemination in Patients with Gastric Carcinoma

Annexin-1 Downregulation is Associated with Clinical Outcome in Chinese Patients with Hilar Cholangiocarcinoma

[The Relation Between Reg 1A Mrna Expression and the Clinicopathologic Parameters in the Patients with Primary Gastric Carcinoma].

Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer

ANXA2 regulates the behavior of SGC-7901 cells.

Interleukin-1α and interleukin-1β in gastric cancer tissue and its clinical significance

ANXA2 Silencing Inhibits Proliferation, Invasion, and Migration in Gastric Cancer Cells

The Expression of NF-κB,IL-8 and CagA in the Peri-Cancer Tissues of Gastric Cancer

Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor/extracellular signal-regulated kinase/integrin beta-1-binding protein 1 pathway

ANXA2 is a Potential Marker for the Diagnosis of Human Cervical Cancer

ANXA1: An Important Independent Prognostic Factor and Molecular Target in Glioma

Expression of anion exchanger 1 is associated with tumor progress in human gastric cancer